{"version":"1.0","type":"link","title":"Serum HER2 extracellular domain as a predictive biomarker for trastuzumab deruxtecan treatment response in HER2-positive gastric cancer: a real-world study.","author_name":"Narita Y 외","author_url":"https://prs-insight.online/author/Narita%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/89928","thumbnail_width":1200,"thumbnail_height":630}